Yahoo
Kuala Lumpur - Delayed Quote MYR

Duopharma Biotech Berhad (7148.KL)

1.1100 -0.0100 (-0.89%)
At close: October 30 at 4:42:42 PM GMT+8
Chart Range Bar
Loading chart for 7148.KL
  • Previous Close 1.1200
  • Open 0.0000
  • Bid 1.1000 x --
  • Ask 1.1100 x --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 1.5700
  • Volume 112,900
  • Avg. Volume 360,688
  • Market Cap (intraday) 1.068B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 10.09
  • EPS (TTM) 0.1100
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.05 (4.10%)
  • Ex-Dividend Date Sep 3, 2026
  • 1y Target Est 1.69

Duopharma Biotech Berhad, together with its subsidiaries, researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally. It offers consumer healthcare products, including vitamins, minerals, and supplements under the Flavettes, PROVITON, PROVITON STR, CHAMPS, and Naturalle brand names; analgesics and antitussives under the Uphamol, Uphacol, and Uphaplast brand names; eyecare products under the Eye Glo brand name; antacids under the Alucid brand name; joint pain products under the Donna brand name; skincare products under Dermoplex brand name; cosmeceuticals under the IRORO Nutreatment brand name; and functional food under the CHAMPS Nutribar and PROVITON STR Powerz brand names. The company also provides generic drugs for various therapeutic areas, such as cardiovascular, dermatology, hormonal, respiratory, sensory and nervous system, musculoskeletal, anti-infectives, and others; and specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables for the treatment of diabetes, cancer, cardiovascular, renal, and other diseases. In addition, it engages in the development of small molecules and biologic therapies for the treatment of Alzheimer's disease; digital therapeutics; and stem cell therapies. Further, the company is involved in property management and services; and distribution of chemical products. It exports its products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.

duopharmabiotech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .

YTD Return

7148.KL
8.24%
FTSE Bursa Malaysia KLCI (^KLSE)
3.84%

1-Year Return

7148.KL
8.24%
FTSE Bursa Malaysia KLCI (^KLSE)
0.09%

3-Year Return

7148.KL
0.65%
FTSE Bursa Malaysia KLCI (^KLSE)
12.26%

5-Year Return

7148.KL
26.24%
FTSE Bursa Malaysia KLCI (^KLSE)
3.41%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY25
Revenue --
Earnings 22.57M
Profit Margin 0.00%

Q1

FY24

Q2

FY24

Q3

FY25

0
50M
100M
150M
200M
0.0%
2.0%
4.0%
6.0%

Analyst Insights

View More

Analyst Price Targets

1.57
1.69 Average
1.1100 Current
1.79 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.00%

  • Return on Assets (ttm)

    6.61%

  • Return on Equity (ttm)

    13.43%

  • Revenue (ttm)

    929.41M

  • Net Income Avi to Common (ttm)

    102.2M

  • Diluted EPS (ttm)

    0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    255.99M

  • Total Debt/Equity (mrq)

    60.30%

  • Levered Free Cash Flow (ttm)

    36.88M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: